MODIFIED ACR COMPOSITE RESPONSE INDEX IN SYSTEMIC SCLEROSIS SCORE SHOWS SENSITIVITY AND EXTERNAL VALIDATION TO MEASURE MAGNITUDE OF RESPONSE AT 12 MONTHS IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

被引:2
|
作者
Abignano, Giuseppina [1 ,2 ,3 ]
Carriero, Antonio [1 ,3 ]
Eng, Sookhoe [1 ,2 ]
Del Galdo, Francesco [1 ,2 ]
机构
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England
[3] Rheumatol Inst Lucania IReL, Rheumatol Dept Lucania, Potenza, Italy
关键词
D O I
10.1136/annrheumdis-2019-eular.7962
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0262
引用
收藏
页码:1207 / 1208
页数:2
相关论文
共 49 条
  • [41] Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
    Eliza F. Chakravarty
    Viktor Martyanov
    David Fiorentino
    Tammara A. Wood
    David James Haddon
    Justin Ansel Jarrell
    Paul J. Utz
    Mark C. Genovese
    Michael L. Whitfield
    Lorinda Chung
    Arthritis Research & Therapy, 17
  • [42] Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis-assessment of individual body sites in two large randomized controlled trials
    Kaldas, Marian
    Khanna, Puja P.
    Furst, Daniel E.
    Clements, Philip J.
    Wong, Weng Kee
    Seibold, James R.
    Postlethwaite, Arnold E.
    Khanna, Dinesh
    RHEUMATOLOGY, 2009, 48 (09) : 1143 - 1146
  • [43] Performance of the American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the Scleroderma Lung Study-I
    Khanna, Dinesh
    Tashkin, Donald P.
    Wilhalme, Holly
    Tseng, Chi-hong
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] Evaluation of American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis in a Phase II Trial of Abatacept Vs. Placebo
    Khanna, Dinesh
    Spino, Cathie
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] EVALUATION OF AMERICAN COLLEGE OF RHEUMATOLOGY PROVISIONAL COMPOSITE RESPONSE INDEX IN SYSTEMIC SCLEROSIS IN A PHASE II TRIAL OF ABATACEPT VS. PLACEBO
    Khanna, Dinesh
    Spino, Cathie
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 845 - 846
  • [46] ANTI-THYMOCYTE GLOBULIN EXPOSURE IS ASSOCIATED WITH TREATMENT RESPONSE IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS UNDERGOING AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Chiu, Y. H.
    Drijver, A.
    Admiraal, R.
    Van Rhenen, A.
    Nierkens, S.
    Van Laar, M.
    Spierings, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1642 - 1642
  • [47] A Possible Contribution of Visfatin to the Resolution of Skin Sclerosis in Patients with Diffuse Cutaneous Systemic Sclerosis Via a Direct Anti-Fibrotic Effect On Dermal Fibroblasts and Th1 Polarization of the Immune Response
    Toyama, Tetsuo
    Asano, Yoshihide
    Masui, Yuri
    Shibata, Sayaka
    Akamata, Kaname
    Noda, Shinji
    Aozasa, Naohiko
    Tanigu-Chi, Takashi
    Takahashi, Takehiro
    Ichimura, Yohei
    Sumida, Hayakazu
    Yanaba, Koichi
    Kadono, Takafumi
    Sato, Shinichi
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S644 - S645
  • [48] A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response
    Masui, Yuri
    Asano, Yoshihide
    Shibata, Sayaka
    Noda, Shinji
    Akamata, Kaname
    Aozasa, Naohiko
    Taniguchi, Takashi
    Takahashi, Takehiro
    Ichimura, Yohei
    Toyama, Tetsuo
    Sumida, Hayakazu
    Yanaba, Koichi
    Tada, Yayoi
    Sugaya, Makoto
    Sato, Shinichi
    Kadono, Takafumi
    RHEUMATOLOGY, 2013, 52 (07) : 1239 - 1244
  • [49] Prognosis and complications of patients with primary gastrointestinal diffuse large B-cell lymphoma: Development and validation of the systemic inflammation response index-covered score
    Chu, Yurou
    Liu, Yingyue
    Jiang, Yujie
    Ge, Xueling
    Yuan, Dai
    Ding, Mei
    Qu, Huiting
    Liu, Fang
    Zhou, Xiangxiang
    Wang, Xin
    CANCER MEDICINE, 2023, 12 (08): : 9570 - 9582